| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 08/01/2006 | US7084115 Supplying oxygen to cells; antiischemic agents; cardiovascular disorders |
| 08/01/2006 | US7084089 Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and a process for preparation of this bidentate diphosphine composition |
| 08/01/2006 | US7083831 Chromium-free corrosion preventive and corrosion prevention method |
| 08/01/2006 | CA2252958C Fungicide salts |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/27/2006 | WO2006078846A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/27/2006 | WO2006078698A1 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases |
| 07/27/2006 | WO2006078021A1 Metal complex containing tridentate ligand, and polymerization catalyst comprising the same |
| 07/27/2006 | WO2006077844A1 Process for producing phosphonitrilic acid ester |
| 07/27/2006 | WO2006009937A3 Novel esters as useful broad spectrum herbicidal compounds |
| 07/27/2006 | WO2005117904A3 Phosphonate analogs of hiv integrase inhibitor compounds |
| 07/27/2006 | US20060167256 dehydration condensation of piperazine diphosphate; component of a flame retardant composition added to synthetic resins |
| 07/27/2006 | US20060167240 compounds comprising a phosphoramidite moiety and a protecting group bonded to a linker chain, and reporter group bonded to the protecting group, used for the functionalization, derivatization and modification that can be introduced into nucleotides |
| 07/27/2006 | US20060167145 Low volatility, has a high phosphorus content, and does not influence various properties of a product; reduced in environmental burden in view of suitability for recycling and contains no halogen atoms; contains 1,3,2-dioxaphosphirnae ring in the molecule; thermal resistance |
| 07/27/2006 | US20060166942 combretastatin A4 phosphate mono-tromethamine in crystalline solid state; salt form increases solubility of combretastatin A4; regenerates native combretastatin A-4 in vivo and do not produce unwanted or potentially deleterious side products when undergoing regeneration |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166936 Diaminotriazole compounds useful as inhibitors of protein kinases |
| 07/27/2006 | US20060166908 Nucloeside analogues and oligonucleotide derivative comprising nucleotide analogue thereof |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/27/2006 | US20060166830 Insecticidal effect even at smaller dosage; soil treatment shows an elevated absorption translocation action from roots for an excellent insecticidal effect; compounds with a N-(pentafluorosulfide-substituted phenyl)phthalamides of given formula |
| 07/27/2006 | US20060166815 Monocyclopentadienyl complexes |
| 07/27/2006 | US20060166197 Building block capable of transferring a functional entity |
| 07/27/2006 | US20060165772 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
| 07/27/2006 | US20060165768 Phosphoramide type cationic lipid compounds such as 3-[[bis(tetradecyloxy)phosphoryl](methyl)amino]-N,N,N-trimethyl-propanaminium iodide; use as nonviral vectors for gene transfer |
| 07/27/2006 | DE102004046665A1 Verwendung von Kupfer(I)-Komplexen in organischen lichtemittierenden Dioden Use of copper (I) complexes in organic light emitting diodes |
| 07/27/2006 | CA2591948A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/26/2006 | EP1684073A2 Target sequences for synthetic molecules and methods of using same |
| 07/26/2006 | EP1683803A1 Water soluble prodrugs of hindered alcohols or phenols |
| 07/26/2006 | EP1683802A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex |
| 07/26/2006 | EP1682559A1 Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles |
| 07/26/2006 | EP1534721B1 Process for controlling the hydrate mix of the disodium salt of fosfluconazole |
| 07/26/2006 | EP1434781B1 Diphosphine |
| 07/26/2006 | EP1363922B1 Novel hydroxyaryl phosphine oxides mixture, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom |
| 07/26/2006 | CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 07/26/2006 | CN1809354A Akt活性抑制剂 Akt activity inhibitor |
| 07/26/2006 | CN1807440A Sodium menadiol diphosphate ester and its pharmaceutical formulation |
| 07/26/2006 | CN1807439A Sodium menadiol diphosphate ester and its pharmaceutical formulation |
| 07/26/2006 | CN1807438A Sodium menadiol diphosphate ester and its pharmaceutical formulation |
| 07/26/2006 | CN1807437A Organophosphorus ester preparation method |
| 07/26/2006 | CN1807436A Method for synthesizing diphosphate using ester exchange method |
| 07/26/2006 | CN1807435A Water soluble phosphate ester salt ofú¿Zú®-3'-hydroxy-3,4',5-trimethoxydiphenyl ethylene, and its preparation method ,pharmaceutical composition and uses |
| 07/26/2006 | CN1266186C One-ingredient moisture-curing epoxy resin composition |
| 07/26/2006 | CN1266157C Method for manufacturing circular chloro-phosphonitrile oligomer |
| 07/26/2006 | CN1266156C Synthesis process for Adefovir ester of anti hepatitis type B virus medicine |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081544 Chiral ligands, transition metal complexes thereof, and the catalytic use of the same |
| 07/25/2006 | US7081536 Complexes; used for catalyst |
| 07/25/2006 | US7081533 Cycloaliphatic/aromatic diphosphines and use thereof in catalysis |
| 07/25/2006 | US7081500 Blocked mercaptosilane coupling agents for filled rubbers |
| 07/25/2006 | US7081469 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 07/25/2006 | CA2182105C Chloropyrimide intermediates |
| 07/20/2006 | WO2006076726A1 Synthesis of sodium narcistatin and related compounds |
| 07/20/2006 | WO2006074983A1 Process for preparing acylphosphanes and their oxides and sulphides |
| 07/20/2006 | WO2006074730A1 Process for the manufacture of aminoalkylenephosphonic acid compounds in the presence of a heterogeneous catalyst |
| 07/20/2006 | WO2006074729A1 Process for the manufacture of aminopolyalkylenephosphonic acid compounds |
| 07/20/2006 | US20060161022 Chiral ligands for application in asymmetric syntheses |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160778 recognize and bind the tubulin site: antitubulin; useful for treating pathological states which arise from or are exacerbated by cell proliferation as anticancer and/or antiangiogenic activity |
| 07/20/2006 | US20060160774 Useful in assisting in the polymerization of monomers in a free radical polymerization that has living-type kinetics |
| 07/20/2006 | US20060160773 Combretastatin derivatives with cytotoxic action |
| 07/20/2006 | US20060160772 Process for manufacture of fosinopril sodium |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160763 System for delivering therapeutic agents into living cells and cells nuclei |
| 07/20/2006 | US20060160694 Supported group-4, group-5, and group-6 metal clusters, preparation of the material and use of the material as a catalyst |
| 07/20/2006 | US20060160125 Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms |
| 07/20/2006 | US20060160068 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker |
| 07/20/2006 | US20060156960 Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete |
| 07/20/2006 | DE19713851B4 Verwendung von Komplexen des Molybdäns, Vanadiums oder Wolframs zur Verstärkung der Bleichwirkung Use of complexes of molybdenum, vanadium or tungsten to enhance the bleaching effect |
| 07/20/2006 | CA2594930A1 Process for the manufacture of aminoalkylenephosphonic acid compounds in the presence of a heterogeneous catalyst |
| 07/20/2006 | CA2594902A1 Process for the manufacture of aminopolyalkylenephosphonic acid compounds |
| 07/20/2006 | CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 07/20/2006 | CA2594569A1 Synthesis of sodium narcistatin and related compounds |
| 07/19/2006 | EP1681295A1 Process for the manufacture of aminoakylenephosphonic acid compounds in the presence of a heterogeneous catalyst |
| 07/19/2006 | EP1681294A1 Process for the manufacture of aminopolyalkylene-phosphonic acid compounds |
| 07/19/2006 | EP1680394A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 07/19/2006 | EP1680382A1 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction using a particular phosphonate which improves diastereoselectivity at all temperatures including at ambient temperature |
| 07/19/2006 | EP1680129A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 07/19/2006 | EP1651717A4 Flameproof thermoplastic resin composition |
| 07/19/2006 | EP1451133A4 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP0831923B1 Separation of active complexes |
| 07/19/2006 | CN1805968A Crystalline carbapenem intermediate |
| 07/19/2006 | CN1805967A Ligands. |
| 07/19/2006 | CN1805966A Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| 07/19/2006 | CN1805928A Prodrugs of mitotic kinesin inhibitors |
| 07/19/2006 | CN1805921A Prodrugs of selective androgen receptor modulators and methods of use thereof |
| 07/19/2006 | CN1805752A Water-soluble shps as novel alkylating agents |
| 07/19/2006 | CN1803811A Nitro imidazole derivative, its preparation method and uses |
| 07/19/2006 | CN1803810A Antiviral agents and preparing method thereof |
| 07/19/2006 | CN1264852C Novel pulveres fosfomycin trometamol synthetic method |
| 07/19/2006 | CN1264851C Metal-diphosphonate crystal material containing chiral skeleton and its preparation process |
| 07/19/2006 | CN1264850C Process for preparation of 2-carboxy-alkyl (aryl) phosphonic acids and anhydrides |
| 07/19/2006 | CN1264842C Method for producing by stereospecific hydration tetrahydropterins and optical pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 07/18/2006 | US7078568 A benzyldihydrophosphine derivatives; hydrogenation catalyst has chemical and enantiomorph selectivity; high catalytic activity, asymmetric synthetic reactions |
| 07/18/2006 | US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs |
| 07/18/2006 | US7078551 Acylthio propylenesilane compounds; no odor, coupling with rubber and inorganic fillers; for use in tires, shoe soles |
| 07/18/2006 | US7078532 Process for manufacture of fosinopril sodium |